United Kingdom · Question · Written question
UIN 64713
Voluntary Scheme for Branded Medicines Pricing and Access
Introduced
27 October 2021
Last action
1 November 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
1 November 2021
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of the Voluntary Scheme for Branded Medicines Pricing and Access on improving patient access to new medicines; and if he will make a statement on the relev
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
27 October 2021
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of the Voluntary Scheme for Branded Medicines Pricing and Access on improving patient access to new medicines; and if he will make a statement on the relev
Source: Commons
1 November 2021
Answer
The National Institute for Health and Care Excellence (NICE) is an independent body and is currently reviewing the methods and processes it uses in its health technology assessments, including considering changes to the discount rate applied to costs and ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-10-27/64713
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1363915
- uk · wq-1363915 · source updated 1 November 2021